Cargando…
Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron
In this report, we mechanistically reveal how the Variant of Concern (VOC) SARS-CoV-2 Omicron (B.1.1.529) escapes neutralizing antibody responses, by physio-chemical characterization of this variant in comparison to the wild-type Wuhan and the Delta variant (B.1.617.2). Convalescent sera, as well as...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147318/ https://www.ncbi.nlm.nih.gov/pubmed/35632499 http://dx.doi.org/10.3390/vaccines10050743 |
_version_ | 1784716777968631808 |
---|---|
author | Vogt, Anne-Cathrine S. Augusto, Gilles Martina, Byron Chang, Xinyue Nasrallah, Gheyath Speiser, Daniel E. Vogel, Monique Bachmann, Martin F. Mohsen, Mona O. |
author_facet | Vogt, Anne-Cathrine S. Augusto, Gilles Martina, Byron Chang, Xinyue Nasrallah, Gheyath Speiser, Daniel E. Vogel, Monique Bachmann, Martin F. Mohsen, Mona O. |
author_sort | Vogt, Anne-Cathrine S. |
collection | PubMed |
description | In this report, we mechanistically reveal how the Variant of Concern (VOC) SARS-CoV-2 Omicron (B.1.1.529) escapes neutralizing antibody responses, by physio-chemical characterization of this variant in comparison to the wild-type Wuhan and the Delta variant (B.1.617.2). Convalescent sera, as well as sera obtained from participants who received two or three doses of mRNA vaccines (Moderna-mRNA-1273(®) or Pfizer-BNT162b2(®)), were used for comparison in this study. Our data demonstrate that both Delta, as well as Omicron variants, exhibit a higher affinity for the receptor ACE2, facilitating infection and causing antibody escape by receptor affinity (affinity escape), due to the reduced ability of antibodies to compete with RBD-receptor interaction and virus neutralization. In contrast, only Omicron but not the Delta variant escaped antibody recognition, most likely because only Omicron exhibits the mutation at E484A, a position associated with reduced recognition, resulting in further reduced neutralization (specificity escape). Nevertheless, the immunizations with RNA-based vaccines resulted in marked viral neutralization in vitro for all strains, compatible with the fact that Omicron is still largely susceptible to vaccination-induced antibodies, despite affinity- and specificity escape. |
format | Online Article Text |
id | pubmed-9147318 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91473182022-05-29 Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron Vogt, Anne-Cathrine S. Augusto, Gilles Martina, Byron Chang, Xinyue Nasrallah, Gheyath Speiser, Daniel E. Vogel, Monique Bachmann, Martin F. Mohsen, Mona O. Vaccines (Basel) Article In this report, we mechanistically reveal how the Variant of Concern (VOC) SARS-CoV-2 Omicron (B.1.1.529) escapes neutralizing antibody responses, by physio-chemical characterization of this variant in comparison to the wild-type Wuhan and the Delta variant (B.1.617.2). Convalescent sera, as well as sera obtained from participants who received two or three doses of mRNA vaccines (Moderna-mRNA-1273(®) or Pfizer-BNT162b2(®)), were used for comparison in this study. Our data demonstrate that both Delta, as well as Omicron variants, exhibit a higher affinity for the receptor ACE2, facilitating infection and causing antibody escape by receptor affinity (affinity escape), due to the reduced ability of antibodies to compete with RBD-receptor interaction and virus neutralization. In contrast, only Omicron but not the Delta variant escaped antibody recognition, most likely because only Omicron exhibits the mutation at E484A, a position associated with reduced recognition, resulting in further reduced neutralization (specificity escape). Nevertheless, the immunizations with RNA-based vaccines resulted in marked viral neutralization in vitro for all strains, compatible with the fact that Omicron is still largely susceptible to vaccination-induced antibodies, despite affinity- and specificity escape. MDPI 2022-05-09 /pmc/articles/PMC9147318/ /pubmed/35632499 http://dx.doi.org/10.3390/vaccines10050743 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Vogt, Anne-Cathrine S. Augusto, Gilles Martina, Byron Chang, Xinyue Nasrallah, Gheyath Speiser, Daniel E. Vogel, Monique Bachmann, Martin F. Mohsen, Mona O. Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron |
title | Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron |
title_full | Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron |
title_fullStr | Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron |
title_full_unstemmed | Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron |
title_short | Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron |
title_sort | increased receptor affinity and reduced recognition by specific antibodies contribute to immune escape of sars-cov-2 variant omicron |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147318/ https://www.ncbi.nlm.nih.gov/pubmed/35632499 http://dx.doi.org/10.3390/vaccines10050743 |
work_keys_str_mv | AT vogtannecathrines increasedreceptoraffinityandreducedrecognitionbyspecificantibodiescontributetoimmuneescapeofsarscov2variantomicron AT augustogilles increasedreceptoraffinityandreducedrecognitionbyspecificantibodiescontributetoimmuneescapeofsarscov2variantomicron AT martinabyron increasedreceptoraffinityandreducedrecognitionbyspecificantibodiescontributetoimmuneescapeofsarscov2variantomicron AT changxinyue increasedreceptoraffinityandreducedrecognitionbyspecificantibodiescontributetoimmuneescapeofsarscov2variantomicron AT nasrallahgheyath increasedreceptoraffinityandreducedrecognitionbyspecificantibodiescontributetoimmuneescapeofsarscov2variantomicron AT speiserdaniele increasedreceptoraffinityandreducedrecognitionbyspecificantibodiescontributetoimmuneescapeofsarscov2variantomicron AT vogelmonique increasedreceptoraffinityandreducedrecognitionbyspecificantibodiescontributetoimmuneescapeofsarscov2variantomicron AT bachmannmartinf increasedreceptoraffinityandreducedrecognitionbyspecificantibodiescontributetoimmuneescapeofsarscov2variantomicron AT mohsenmonao increasedreceptoraffinityandreducedrecognitionbyspecificantibodiescontributetoimmuneescapeofsarscov2variantomicron |